Cancer clinical trials are a critically important step on the pathway for new or improved treatments to make their way to patients in clinics and hospitals in towns and cities across the country. Patients and their loved ones are relying on these rigorous studies to determine whether promising new therapies and approaches might extend how long they live or improve their quality of life. For many years, a steady number of patients with cancer, approximately 5%, have participated in cancer clinical trials.
Michael Balint is a Presidential Innovation Fellow.
- Health Tech Sprint Aims at Improving Care Access and Experience
- GSA Steps Up Security for .gov
- A Design Challenge to Improve How School Data is Reported
- Want a More Innovative Agency? Encourage Employees to Experiment
- Collaborating for Better Design, Technology, and User Experience